Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1550 of 1631 entries
View as:

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice

Phase: N/A Priority: Normal
NCT ID: NCT01915264 Org: User:
Start: 08/31/15 End: 03/31/17 Due: 03/31/18

A Study Run At Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also Be Used to Assess Changes of Severity of HMB in Women with HMB Who Are Treated During 12 Months with a Chronic Hormonal Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03751800 Org: User:
Start: 12/12/18 End: 05/18/21 Due: 05/18/22

Betaferon Use in Children and Adolescents With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03577977 Org: User:
Start: 06/01/08 End: 04/15/09 Due: 04/15/10

Human Phototoxicity Test

Phase: N/A Priority: Normal
NCT ID: NCT02750475 Org: User:
Start: 05/02/16 End: 05/06/16 Due: 05/06/17

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

Phase: N/A Priority: Normal
NCT ID: NCT02349399 Org: User:
Start: 05/01/15 End: 03/01/16 Due: 03/01/17

LCS12 Adolescent Study

Phase: N/A Priority: Normal
NCT ID: NCT01434160 Org: User:
Start: 09/30/11 End: 05/31/15 Due: 05/31/16

HPA Axis Study in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01408511 Org: User:
Start: 07/19/11 End: 12/21/11 Due: 12/21/12

Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00791778 Org: User:
Start: 11/30/08 End: 12/31/12 Due: 12/31/13

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT01915602 Org: User:
Start: 09/27/13 End: 02/08/17 Due: 02/08/18

Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01938638 Org: User:
Start: 09/26/13 End: 09/19/16 Due: 09/19/17

A Study to Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Through, and Out of the Body if Given in Single and in Repetitive Doses to Japanese Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05563454 Org: User:
Start: 10/11/22 End: 02/28/23 Due: 02/28/24

Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium

Phase: N/A Priority: Normal
NCT ID: NCT01389284 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients

Phase: N/A Priority: Normal
NCT ID: NCT01817868 Org: User:
Start: 01/04/13 End: 05/23/19 Due: 05/23/20

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01914380 Org: User:
Start: 07/29/13 End: 03/31/17 Due: 03/31/18

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

Phase: N/A Priority: Normal
NCT ID: NCT02032836 Org: User:
Start: 03/10/14 End: 09/29/17 Due: 09/29/18

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Phase: N/A Priority: Normal
NCT ID: NCT03214172 Org: User:
Start: 07/15/17 End: 09/15/17 Due: 09/15/18

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Phase: N/A Priority: Normal
NCT ID: NCT04444804 Org: User:
Start: 07/31/20 End: 04/30/21 Due: 04/30/22

Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01204177 Org: User:
Start: 12/31/10 End: 08/31/13 Due: 08/31/14

Primovist Regulatory Post Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT00924248 Org: User:
Start: 10/31/07 End: 05/31/11 Due: 05/31/12

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

Phase: N/A Priority: Normal
NCT ID: NCT03311139 Org: User:
Start: 11/16/17 End: 03/23/18 Due: 03/23/19

Effect of Copanlisib on Metformin Pharmacokinetics and Pharmacodynamics

Phase: N/A Priority: Normal
NCT ID: NCT03655301 Org: User:
Start: 09/11/18 End: 02/12/19 Due: 02/12/20

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.

Phase: N/A Priority: Normal
NCT ID: NCT04920422 Org: User:
Start: 07/15/21 End: 10/07/22 Due: 10/07/23

Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00998673 Org: User:
Start: 04/30/09 End: 06/30/11 Due: 06/30/12

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

Phase: N/A Priority: Normal
NCT ID: NCT04085458 Org: User:
Start: 09/23/19 End: 08/26/22 Due: 08/26/23

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

Phase: N/A Priority: Normal
NCT ID: NCT02959827 Org: User:
Start: 10/15/16 End: 06/15/17 Due: 06/15/18